235 related articles for article (PubMed ID: 27855621)
21. Recent advances in α-1-antitrypsin deficiency-related lung disease.
Brebner JA; Stockley RA
Expert Rev Respir Med; 2013 Jun; 7(3):213-29; quiz 230. PubMed ID: 23734645
[TBL] [Abstract][Full Text] [Related]
22. How Can We Improve the Detection of Alpha1-Antitrypsin Deficiency?
Ferrarotti I; Poplawska-Wisniewska B; Trevisan MT; Koepke J; Dresel M; Koczulla R; Ottaviani S; Baldo R; Gorrini M; Sala G; Cavallon L; Welte T; Chorostowska-Wynimko J; Luisetti M; Janciauskiene S
PLoS One; 2015; 10(8):e0135316. PubMed ID: 26270547
[TBL] [Abstract][Full Text] [Related]
23. Emerging drugs for alpha-1-antitrypsin deficiency.
Stockley RA
Expert Opin Emerg Drugs; 2010 Dec; 15(4):685-94. PubMed ID: 20716026
[TBL] [Abstract][Full Text] [Related]
24. alpha 1-antitrypsin deficiency-associated panniculitis: resolution with intravenous alpha 1-antitrypsin administration and liver transplantation.
O'Riordan K; Blei A; Rao MS; Abecassis M
Transplantation; 1997 Feb; 63(3):480-2. PubMed ID: 9039946
[TBL] [Abstract][Full Text] [Related]
25. Linkage analysis of alpha 1-antitrypsin deficiency: lessons for complex diseases.
Silverman EK; Mosley JD; Rao DC; Palmer LJ; Province MA; Elston RC; Weiss ST; Campbell EJ
Hum Hered; 2001; 52(4):223-32. PubMed ID: 11713419
[TBL] [Abstract][Full Text] [Related]
26. Alpha-1-antitrypsin aerosolised augmentation abrogates neutrophil elastase-induced expression of cathepsin B and matrix metalloprotease 2 in vivo and in vitro.
Geraghty P; Rogan MP; Greene CM; Brantly ML; O'Neill SJ; Taggart CC; McElvaney NG
Thorax; 2008 Jul; 63(7):621-6. PubMed ID: 18250185
[TBL] [Abstract][Full Text] [Related]
27. Alpha-1-antitrypsin is produced by human neutrophil granulocytes and their precursors and liberated during granule exocytosis.
Clemmensen SN; Jacobsen LC; Rørvig S; Askaa B; Christenson K; Iversen M; Jørgensen MH; Larsen MT; van Deurs B; Ostergaard O; Heegaard NH; Cowland JB; Borregaard N
Eur J Haematol; 2011 Jun; 86(6):517-30. PubMed ID: 21477074
[TBL] [Abstract][Full Text] [Related]
28. Alpha-1 Antitrypsin and Lung Cell Apoptosis.
Serban KA; Petrache I
Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2(Suppl 2):S146-9. PubMed ID: 27115949
[TBL] [Abstract][Full Text] [Related]
29. Fibromyalgia, mood disorders, and intense creative energy: A1AT polymorphisms are not always silent.
Schmechel DE; Edwards CL
Neurotoxicology; 2012 Dec; 33(6):1454-1472. PubMed ID: 22414631
[TBL] [Abstract][Full Text] [Related]
30. [Alpha-1 antitrypsin deficiency: diagnosis and treatment].
Camelier AA; Winter DH; Jardim JR; Barboza CE; Cukier A; Miravitlles M
J Bras Pneumol; 2008 Jul; 34(7):514-27. PubMed ID: 18695797
[TBL] [Abstract][Full Text] [Related]
31. Alpha-1-antitrypsin in pathogenesis of hepatocellular carcinoma.
Topic A; Ljujic M; Radojkovic D
Hepat Mon; 2012 Oct; 12(10 HCC):e7042. PubMed ID: 23162602
[TBL] [Abstract][Full Text] [Related]
32. Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency.
McLean C; Greene CM; McElvaney NG
Biologics; 2009; 3():63-75. PubMed ID: 19707397
[TBL] [Abstract][Full Text] [Related]
33. High-level production of wild-type and oxidation-resistant recombinant alpha-1-antitrypsin in glycoengineered CHO cells.
Koyuturk I; Kedia S; Robotham A; Star A; Brochu D; Sauvageau J; Kelly J; Gilbert M; Durocher Y
Biotechnol Bioeng; 2022 Sep; 119(9):2331-2344. PubMed ID: 35508753
[TBL] [Abstract][Full Text] [Related]
34. Clinical heterogeneity and potential high pathogenicity of the Mmalton Alpha 1 antitrypsin allele at the homozygous, compound heterozygous and heterozygous states.
Joly P; Guillaud O; Hervieu V; Francina A; Mornex JF; Chapuis-Cellier C
Orphanet J Rare Dis; 2015 Oct; 10():130. PubMed ID: 26446624
[TBL] [Abstract][Full Text] [Related]
35. The Diagnostic Value of Alpha-1-Antitrypsin Phenotype in Patients with Granulomatosis with Polyangiitis.
Pervakova MY; Emanuel VL; Titova ON; Lapin SV; Mazurov VI; Belyaeva IB; Chudinov AL; Blinova TV; Surkova EA
Int J Rheumatol; 2016; 2016():7831410. PubMed ID: 27127514
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency.
Petrache I; Hajjar J; Campos M
Biologics; 2009; 3():193-204. PubMed ID: 19707408
[TBL] [Abstract][Full Text] [Related]
37. The alpha 1-antitrypsin gene and its deficiency states.
Crystal RG
Trends Genet; 1989 Dec; 5(12):411-7. PubMed ID: 2696185
[TBL] [Abstract][Full Text] [Related]
38. Oncostatin M and TNF-α Induce Alpha-1 Antitrypsin Production in Undifferentiated Adipose Stromal Cells.
Ni K; Umair Mukhtar Mian M; Meador C; Gill A; Barwinska D; Cao D; Justice MJ; Jiang D; Schaefer N; Schweitzer KS; Chu HW; March KL; Petrache I
Stem Cells Dev; 2017 Oct; 26(20):1468-1476. PubMed ID: 28825379
[TBL] [Abstract][Full Text] [Related]
39. Alpha 1-antitrypsin deficiency: an overview.
van Steenbergen W
Acta Clin Belg; 1993; 48(3):171-89. PubMed ID: 8396299
[TBL] [Abstract][Full Text] [Related]
40. hiPSC hepatocyte model demonstrates the role of unfolded protein response and inflammatory networks in α
Segeritz CP; Rashid ST; de Brito MC; Serra MP; Ordonez A; Morell CM; Kaserman JE; Madrigal P; Hannan NRF; Gatto L; Tan L; Wilson AA; Lilley K; Marciniak SJ; Gooptu B; Lomas DA; Vallier L
J Hepatol; 2018 Oct; 69(4):851-860. PubMed ID: 29879455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
